Celcuity LLC

NASDAQ:CELC USA Biotechnology
Market Cap
$5.28 Billion
Market Cap Rank
#3563 Global
#2325 in USA
Share Price
$114.11
Change (1 day)
-0.69%
52-Week Range
$8.21 - $117.25
All Time High
$117.25
About

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2… Read more

Celcuity LLC (CELC) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.383x

Based on the latest financial reports, Celcuity LLC (CELC) has a cash flow conversion efficiency ratio of -0.383x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-44.82 Million) by net assets ($116.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Celcuity LLC - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Celcuity LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Celcuity LLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celcuity LLC ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Celcuity LLC (2015–2024)

The table below shows the annual cash flow conversion efficiency of Celcuity LLC from 2015 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $115.62 Million $-83.47 Million -0.722x -87.51%
2023-12-31 $139.77 Million $-53.81 Million -0.385x -43.03%
2022-12-31 $133.77 Million $-36.01 Million -0.269x +8.94%
2021-12-31 $68.71 Million $-20.31 Million -0.296x +51.59%
2020-12-31 $11.70 Million $-7.15 Million -0.611x -96.43%
2019-12-31 $19.30 Million $-6.00 Million -0.311x -29.68%
2018-12-31 $25.35 Million $-6.08 Million -0.240x -52.07%
2017-12-31 $31.39 Million $-4.95 Million -0.158x +69.38%
2016-12-31 $5.61 Million $-2.89 Million -0.515x -30.48%
2015-12-31 $5.02 Million $-1.98 Million -0.394x --